BSD-2000 Hyperthermia System: Phase I/II started

BSD began the open-label, German Phase I/II HyRec trial to evaluate the BSD-2000 Hyperthermia System in combination with 5-fluorouracil (5-FU) and oxaliplatin chemotherapy and radiotherapy in about 59...